Differences among lesions with exon 19, exon 21 EGFR mutations and wild types in surgically resected non-small cell lung cancer | Scientific Reports
Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nationwide registry study - The Lancet Regional Health –
Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis | European Respiratory Society
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC | NEJM
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC | NEJM
The benefit of anti-angiogenic therapy in EGFR exon 21 L858R mutant non-small cell lung cancer patients: a retrospective study | Scientific Reports
First-line osimertinib in elderly patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer: a retrospective multicenter study (HOT2002) | Scientific Reports
Kaplan-Meier curves for overall survival of lung adenocarcinoma... | Download Scientific Diagram
Overall survival (OS) curves of EGFR‑mutated patients treated with... | Download Scientific Diagram
Critical Review of *EGFR*-Mutated NSCLC What We Do and Do Not Know | Published in healthbook TIMES Oncology Hematology
Structure-based classification predicts drug response in EGFR-mutant NSCLC | Nature
Kaplan-Meier PFS (A) and OS (B) curves for the all NSCLC patients... | Download Scientific Diagram
Patients with advanced non‑small cell lung cancer with EGFR mutations in addition to complex mutations treated with osimertinib have a poor clinical outcome: A real‑world data analysis
An exon 21 L858R EGFR mutation is associated with a decreased survival... | Download Scientific Diagram
Cancers | Free Full-Text | Treatment Strategies for Non-Small Cell Lung Cancer Harboring Common and Uncommon EGFR Mutations: Drug Sensitivity Based on Exon Classification, and Structure-Function Analysis
Association between EGFR exon 19 or exon 21 mutations and survival rates after first‑line EGFR‑TKI treatment in patients with non‑small cell lung cancer
Survival‑associated factors of first‑line EGFR‑tyrosine kinase inhibitor responders and non‑responders in lung adenocarcinoma patients with common EGFR mutations
THE LIVES AFFECTED BY EGFR EXON 20 INSERTION MUTATIONS
Kaplan–Meier estimates of overall survival according to EGFR status... | Download Scientific Diagram
Overall survival of EGFR-mutated lung adenocarcinoma patients with or... | Download Scientific Diagram
Real world treatment and outcomes in EGFR mutation-positive non-small cell lung cancer: Long-term follow-up of a large patient cohort - ScienceDirect
The prognostic role of EGFR-TKIs for patients with advanced non-small cell lung cancer | Scientific Reports
EGFR Exon 20 Insertions
EGFR-mutated disease: early combinations and new approaches in exon 20 insertion-positive lung cancer - memoinOncology
Survival past five years with advanced, EGFR-mutated or ALK-rearranged non-small cell lung cancer—is there a “tail plateau” in the survival curve of these patients? | BMC Cancer | Full Text
Overall survival in patients with EGFR exon 20 insertions and major... | Download Scientific Diagram
